Geron Corporation (GERN) Financials

GERN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 394.1 million 146.1 million
2023-09-30 413.0 million 122.4 million
2023-06-30 415.3 million 116.9 million
2023-03-31 424.9 million 98.8 million

GERN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -40.4 million 4.4 million
2023-09-30 -51.0 million 7.2 million
2023-06-30 -29.8 million 3.9 million
2023-03-31 -46.7 million 3.0 million

GERN Net Income

No data available :(

GERN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 334.8 million - 4.0 million
2023-09-30 313.5 million - 4.1 million
2023-06-30 371.4 million - 4.3 million
2023-03-31 381.1 million 51.4 million 4.4 million

GERN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 595.0 million
2023-09-30 579.5 million
2023-06-30 547.3 million
2023-03-31 544.5 million

GERN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 64000 32.9 million 21.4 million 241000
2023-09-30 192000 29.4 million 18.4 million -
2023-06-30 202000 35.5 million 16.5 million -
2023-03-31 372000 27.2 million 12.9 million -

GERN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 23000 241000
2023-09-30 164000 29.4 million
2023-06-30 29000 275000
2023-03-31 21000 251000

GERN

Price: $3.77

52 week price:
1.64
4.14

Earnings Per Share: -0.32 USD

P/E Ratio: -5.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 535483

Ebitda: -6.9 million

Market Capitalization: 2.0 billion

Links: